Our scientists sequence microbial genomes to map functional potential and guide development. Where naturally high-performing microbes advance, targeted non-GMO gene editing is applied to enhance specific traits. In other markets, microbes advance without modification.
This approach allows a single platform to support multiple regulatory environments while maintaining performance, stability and scalability. Partners gain access to differentiated innovation without sacrificing market access.
